AGILE CST2 Press Release
We have published a paper with the results from the first AGILE trial using molnupiravir in The Lancet Infectious Diseases Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised,…
Read more